| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
66,141 |
48,677 |
$5.02M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,871 |
4,869 |
$450K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,183 |
4,180 |
$421K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,454 |
4,385 |
$413K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,112 |
3,533 |
$360K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
18,869 |
17,635 |
$186K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,640 |
1,634 |
$169K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,305 |
3,063 |
$120K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,142 |
1,142 |
$118K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
3,968 |
3,965 |
$89K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
33,556 |
30,059 |
$80K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,929 |
3,702 |
$79K |
| 87428 |
|
3,895 |
3,601 |
$75K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,129 |
14,901 |
$48K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
187 |
187 |
$28K |
| 92570 |
|
1,905 |
1,733 |
$23K |
| 96127 |
|
4,709 |
4,676 |
$22K |
| 81000 |
|
5,932 |
5,546 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
344 |
325 |
$17K |
| 99383 |
|
153 |
153 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
704 |
683 |
$15K |
| 90461 |
|
4,445 |
4,385 |
$12K |
| 92588 |
|
229 |
227 |
$11K |
| 93000 |
|
809 |
797 |
$9K |
| 94664 |
|
942 |
941 |
$8K |
| 99384 |
|
54 |
54 |
$6K |
| 90716 |
|
1,086 |
1,084 |
$6K |
| 90651 |
|
529 |
529 |
$5K |
| 96160 |
|
1,930 |
1,915 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
39 |
36 |
$4K |
| 97802 |
|
8,071 |
8,065 |
$4K |
| 92587 |
|
109 |
109 |
$3K |
| 90686 |
|
3,262 |
3,254 |
$3K |
| 81025 |
|
1,553 |
1,518 |
$3K |
| 90707 |
|
475 |
474 |
$3K |
| 90715 |
|
1,222 |
1,221 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
153 |
146 |
$1K |
| 99382 |
|
12 |
12 |
$1K |
| 90710 |
|
1,391 |
1,390 |
$924.00 |
| 90744 |
|
2,077 |
2,071 |
$871.37 |
| 90473 |
|
157 |
157 |
$783.54 |
| 90619 |
|
1,058 |
1,055 |
$730.69 |
| 36415 |
Collection of venous blood by venipuncture |
5,451 |
5,330 |
$579.76 |
| 90677 |
|
451 |
449 |
$570.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
570 |
546 |
$458.99 |
| 99173 |
|
5,572 |
5,551 |
$206.22 |
| 90633 |
|
1,718 |
1,714 |
$203.25 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
13 |
$194.94 |
| 90674 |
|
117 |
117 |
$141.94 |
| 90672 |
|
968 |
967 |
$140.92 |
| 81002 |
|
65 |
63 |
$128.48 |
| 90734 |
|
839 |
837 |
$110.52 |
| 82947 |
|
38 |
37 |
$110.20 |
| 86580 |
|
14 |
13 |
$58.00 |
| 90713 |
|
528 |
525 |
$45.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
112 |
106 |
$10.35 |
| A7015 |
Aerosol mask, used with dme nebulizer |
12 |
12 |
$8.91 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$8.27 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
153 |
146 |
$4.67 |
| 36416 |
|
27,306 |
24,336 |
$3.24 |
| 90685 |
|
59 |
59 |
$0.00 |
| 90700 |
|
399 |
399 |
$0.00 |
| 90670 |
|
1,803 |
1,798 |
$0.00 |
| 90671 |
|
120 |
120 |
$0.00 |
| 90681 |
|
53 |
53 |
$0.00 |
| 90647 |
|
428 |
428 |
$0.00 |
| 90698 |
|
1,555 |
1,549 |
$0.00 |
| 90696 |
|
632 |
631 |
$0.00 |
| 90680 |
|
1,539 |
1,532 |
$0.00 |
| 90697 |
|
350 |
348 |
$0.00 |
| 90723 |
|
12 |
12 |
$0.00 |